Treatment of Non Ulcer dyspepsia with Unani medicine Majoon-e-Sangdana Murgh
- Conditions
- Health Condition 1: K30- Functional dyspepsiaHealth Condition 2: K30- Functional dyspepsia
- Registration Number
- CTRI/2018/10/015910
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1 Patients of either sex in the age group of 18-60
2 Patients meeting the Rome III diagnostic criteria for PDS
1 Presence of GI ulcer, erosive gastritis, atrophic gastritis, severe dysplasia of gastric mucosa or suspicious malignant lesion.
2 Having overlap syndrome combined with gastro esophageal reflux disease or irritable bowel syndrome
3 Having alarm symptoms (weight loss, black or tar stool, dysphasia, etc.)
4 Having any systemic disease (diseases of heart, lung, liver or kidney) or mental illness
5 History of surgery related with the gastrointestinal tract more than six months ago
6 Taking drugs which may affect the gastro intestinal tract, such as non-steroidal anti-inflammatory drugs and aspirin
7 Known Allergy to the experimental medications
8 Pregnant and breastfeeding
9 Refusing to sign the informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in signs and symptoms of Duâ??f al-Miâ??da (Functional Dyspepsia)Timepoint: Six weeks
- Secondary Outcome Measures
Name Time Method Haematological and biochemical assessment for safety assessmentTimepoint: At baseline and end of treatment